(Q36754806)

English

Systematic review of early vs deferred hormonal treatment of locally advanced prostate cancer: a meta-analysis of randomized controlled trials

scientific article published on 6 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

0 references

1 reference

Europe PubMed Central

Systematic review of early vs deferred hormonal treatment of locally advanced prostate cancer: a meta-analysis of randomized controlled trials (English)

1 reference

Europe PubMed Central

16 August 2017

systematic review

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Gregory Boustead

1

1 reference

Europe PubMed Central

16 August 2017

Steven J Edwards

2

1 reference

Europe PubMed Central

16 August 2017

publication date

6 March 2007

1 reference

Europe PubMed Central

16 August 2017

BJU International

1 reference

Europe PubMed Central

16 August 2017

99

1 reference

Europe PubMed Central

16 August 2017

6

1 reference

Europe PubMed Central

16 August 2017

1383-1389

1 reference

Europe PubMed Central

16 August 2017

Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Prostate cancer management: 2. An update on locally advanced and metastatic disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Allocation of patients to treatment groups in a controlled clinical study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

The randomization and stratification of patients to clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06802.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2007.06802.X

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36754806&oldid=1655330359"